MESMULOGENE ANCOVACIVEC
UNII WQQ9XZH2CC

Substance Identification & Data

This profile provides standardized clinical and technical data for Mesmulogene Ancovacivec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WQQ9XZH2CC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1246525-59-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WQQ9XZH2CC
CAS Registry Number
1246525-59-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MESMULOGENE ANCOVACIVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10254
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mesmulogene Ancovacivec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MESMULOGENE ANCOVACIVEC

Common Names & Synonyms

AN ANTITUMOR VACCINE CONTAINING A RECOMBINANT MODIFIED VIRUS ANKARA EXPRESSING INTERLEUKIN 2 AND THE TUMOR-ASSOCIATED ANTIGEN MUC1
MESMULOGENE ANCOVACIVEC [INN]
MVA-MUC1-IL2 (MESMULOGENE ANCOVACIVEC)
TG 4010 [WHO-DD]

Technical Codes

TG4010
TG-4010